Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Videos

Stefan Holubar
Video
Stefan Holubar, MD, on Perioperative Management of IBD
03/24/2023
Dr Holubar reviewed the key steps to preparing patients with inflammatory bowel disease for surgery to ensure the best possible outcomes at the Advances in Inflammatory Bowel Diseases virtual regional meeting April 20-21.
Dr Holubar reviewed the key steps to preparing patients with inflammatory bowel disease for surgery to ensure the best possible outcomes at the Advances in Inflammatory Bowel Diseases virtual regional meeting April 20-21.
Dr Holubar reviewed the key...
03/24/2023
Advances in Inflammatory Bowel Disease Network
Jeffrey Berinstein
Video
Jeffrey Berinstein, MD, on Using JAK Inhibitors Upfront in ASUC
03/20/2023
Dr Berinstein recaps his 'pitch' for the use of JAK inhibitors with corticosteroids to control acute severe ulcerative colitis, which he made to the "Shark Tank" panel at the Crohn's & Colitis Congress.
Dr Berinstein recaps his 'pitch' for the use of JAK inhibitors with corticosteroids to control acute severe ulcerative colitis, which he made to the "Shark Tank" panel at the Crohn's & Colitis Congress.
Dr Berinstein recaps his 'pitch'...
03/20/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Sam Eisenstein
Video
Samuel Eisenstein, MD, on the Surgeon's Role in Acute Severe Ulcerative Colitis
03/14/2023
Dr Eisenstein reviews key reasons to involve a colorectal surgeon early in the care of patients with acute severe ulcerative colitis, rather than waiting until surgery has become a necessity.
Dr Eisenstein reviews key reasons to involve a colorectal surgeon early in the care of patients with acute severe ulcerative colitis, rather than waiting until surgery has become a necessity.
Dr Eisenstein reviews key...
03/14/2023
Advances in Inflammatory Bowel Disease Network
Aline Charabaty
Conference Coverage
Aline Charabaty, MD, on Managing Mild Crohn Disease
03/12/2023
Dr Charabaty, from Johns Hopkins Sibley Memorial Hospital in Washington, DC, reviews her presentation from Advances in Inflammatory Bowel Disease 2022 on treating mild Crohn disease in adults and children.
Dr Charabaty, from Johns Hopkins Sibley Memorial Hospital in Washington, DC, reviews her presentation from Advances in Inflammatory Bowel Disease 2022 on treating mild Crohn disease in adults and children.
Dr Charabaty, from Johns Hopkins...
03/12/2023
Advances in Inflammatory Bowel Disease Network
Jessica Salwen-Deremer
Video
Jessica Salwen-Deremer, PhD, on Fatigue Among Patients With IBD
03/06/2023
Dr Salwen-Deremer discusses how the use of cognitive behavioral therapy can help relieve sleep disruption and other factors that contribute to fatigue among patients with inflammatory bowel disease.
Dr Salwen-Deremer discusses how the use of cognitive behavioral therapy can help relieve sleep disruption and other factors that contribute to fatigue among patients with inflammatory bowel disease.
Dr Salwen-Deremer discusses how...
03/06/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Miguel Regueiro MD
Video
Miguel Regueiro, MD, on Medical-Surgical Conundrums in IBD
03/02/2023
Dr Regueiro discusses his presentation at GUILD 2023 on multidisciplinary approaches needed to manage anal strictures, peristomal complications, diversion colitis and proctitis, pouchitis and other complications of inflammatory bowel disease.
Dr Regueiro discusses his presentation at GUILD 2023 on multidisciplinary approaches needed to manage anal strictures, peristomal complications, diversion colitis and proctitis, pouchitis and other complications of inflammatory bowel disease.
Dr Regueiro discusses his...
03/02/2023
Advances in Inflammatory Bowel Disease Network
Parambir Dulai
Video
Parambir Dulai, MD on Using Decision Support Tools for IBD
02/16/2023
Dr Dulai, from Northwestern University in Chicago, discusses the use of decision support tools to help clinicians choose and maximize therapies for patients with inflammatory bowel disease rather than trying to force an individual patient's...
Dr Dulai, from Northwestern University in Chicago, discusses the use of decision support tools to help clinicians choose and maximize therapies for patients with inflammatory bowel disease rather than trying to force an individual patient's...
Dr Dulai, from Northwestern...
02/16/2023
Advances in Inflammatory Bowel Disease Network
Ed Loftus
Conference Coverage
Edward Loftus, MD, on Primary Sclerosing Cholangitis and Neoplasia in IBD
02/05/2023
Dr Loftus, from the Mayo Clinic in Rochester, Minnesota, reviews the risks of cancer among patients with primary sclerosing cholangitis and inflammatory bowel disease, including bile duct cancer and hepatocellular carcinoma, and how to...
Dr Loftus, from the Mayo Clinic in Rochester, Minnesota, reviews the risks of cancer among patients with primary sclerosing cholangitis and inflammatory bowel disease, including bile duct cancer and hepatocellular carcinoma, and how to...
Dr Loftus, from the Mayo Clinic...
02/05/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Millie Long
Conference Coverage
Millie Long, MD, on Malignancy Risks in IBD
01/21/2023
Dr Long spoke at the Crohn's & Colitis Congress 2023 in Denver, Colorado, on the risks of malignancy associated with inflammatory bowel disease and how to discuss absolute risks with patients when choosing therapy.
Dr Long spoke at the Crohn's & Colitis Congress 2023 in Denver, Colorado, on the risks of malignancy associated with inflammatory bowel disease and how to discuss absolute risks with patients when choosing therapy.
Dr Long spoke at the Crohn's &...
01/21/2023
Advances in Inflammatory Bowel Disease Network
Jami Kinnucan
Conference Coverage
Jami Kinnucan, MD, on Implementing a Treat to Target Strategy for IBD
01/20/2023
Dr Kinnucan reviews her presentation to advanced practice professionals at the Crohn's & Colitis Congress on implementing a treat to target strategy for patients with inflammatory bowel disease.
Dr Kinnucan reviews her presentation to advanced practice professionals at the Crohn's & Colitis Congress on implementing a treat to target strategy for patients with inflammatory bowel disease.
Dr Kinnucan reviews her...
01/20/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest News

News
Lupus and IBD Share Microbiome Features
10/18/2024
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Standard Dosing of Infliximab Effective for Steroid-Refractory ASUC
10/18/2024
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
The Risks of Placebo in IBD Drug Trials
10/18/2024
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Endoscopic Healing Index Shows Limited Utility for Identifying CD Remission
10/08/2024
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of...
10/08/2024
Advances in Inflammatory Bowel Disease Network
News
Scores Predict Corticosteroid Failure Risk in Patients With ASUC
10/03/2024
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that...
10/03/2024
Advances in Inflammatory Bowel Disease Network
News
Previous Stricturing Increases Risk of Anastomotic Stricture in Postoperative CD
10/01/2024

Jolynn Tumolo

Jolynn Tumolo
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment...
10/01/2024
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistence in CD Patients With Prior Biologic Use
09/30/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
09/30/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Shows Efficacy Among Biologic-Exposed Patients With Crohn’s Disease
09/24/2024
A recent study revealed upadacitinib significantly improved clinical and endoscopic outcomes, even among patients with prior biologic failure.
A recent study revealed upadacitinib significantly improved clinical and endoscopic outcomes, even among patients with prior biologic failure.
A recent study revealed...
09/24/2024
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Guselkumab for Moderate to Severe Ulcerative Colitis
09/12/2024
Johnson & Johnson’s guselkumab is the first and only fully-human, dual-acting monoclonal antibody that blocks IL-23 and binds to CD64.
Johnson & Johnson’s guselkumab is the first and only fully-human, dual-acting monoclonal antibody that blocks IL-23 and binds to CD64.
Johnson & Johnson’s guselkumab...
09/12/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Provides Rapid Response in Crohn's Disease
08/29/2024
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction...
08/29/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest Podcasts

Freddy Caldera
Podcast
Freddy Caldera, DO, on the RSV Vaccine for Patients With IBD
10/11/2024
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University...
10/11/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Updates on the PIANO Study of IBD and Pregnancy
10/07/2024
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie...
10/07/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: David Hudesman, MD, on Work Productivity in IBD
09/19/2024
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone...
09/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Jordan Axelrad, MD, on IBD and Malignancy
08/19/2024
Dr Jordan Axelrad and host Dr Raymond Cross discuss the considerations for IBD treatment among patients with history of or a newly-diagnosed malignancy, including when to switch IBD treatments, the importance of controlling disease, and how...
Dr Jordan Axelrad and host Dr Raymond Cross discuss the considerations for IBD treatment among patients with history of or a newly-diagnosed malignancy, including when to switch IBD treatments, the importance of controlling disease, and how...
Dr Jordan Axelrad and host Dr...
08/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
06/24/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
06/24/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use